Primaquine-Induced Hemolytic Anemia: Role of Membrane Lipid Peroxidation and Cytoskeletal Protein Alterations in the Hemotoxicity of 5-Hydroxyprimaquine
- 19 April 2005
- journal article
- Published by American Society for Pharmacology & Experimental Therapeutics (ASPET) in The Journal of pharmacology and experimental therapeutics
- Vol. 314 (2), 838-845
- https://doi.org/10.1124/jpet.105.086488
Abstract
Primaquine-induced hemolytic anemia is a toxic side effect that is due to premature splenic sequestration of intact erythrocytes. Previous studies have suggested that a phenolic metabolite, 5-hydroxyprimaquine (5-HPQ), mediates primaquine hemotoxicity by generating reactive oxygen species (ROS) within erythrocytes that overwhelm antioxidant defenses. However, the nature of the oxidative stress is not understood, and the molecular targets, whether protein and/or lipid, are unknown. To investigate the mechanism underlying the hemolytic activity of 5-HPQ, we have examined the effect of hemolytic concentrations of 5-HPQ on ROS formation within rat erythrocytes using the cellular ROS probe, 2′,7′-dichlorodihydrofluoresein diacetate. In addition, we examined the effect of 5-HPQ on membrane lipids and cytoskeletal proteins. The data indicate that 5-HPQ causes a prolonged, concentration-dependent generation of ROS within erythrocytes. Interestingly, 5-HPQ-generated ROS was not associated with the onset of lipid peroxidation or an alteration in phosphatidylserine asymmetry. Instead, 5-HPQ induced oxidative injury to the erythrocyte cytoskeleton, as evidenced by changes in the normal electrophoretic pattern of membrane ghost proteins. Immunoblotting with an anti-hemoglobin antibody revealed that these changes were due primarily to the formation of disulfide-linked hemoglobin-skeletal protein adducts. The data suggest that cytoskeletal protein damage, rather than membrane lipid peroxidation or loss of phosphatidylserine asymmetry, underlies the process of removal of erythrocytes exposed to 5-HPQ.This publication has 31 references indexed in Scilit:
- Protein 4.2 is critical to CD47-membrane skeleton attachment in human red cellsBlood, 2004
- Primaquine-Induced Hemolytic Anemia: Susceptibility of Normal versus Glutathione-Depleted Rat Erythrocytes to 5-HydroxyprimaquineThe Journal of pharmacology and experimental therapeutics, 2004
- A band 3-based macrocomplex of integral and peripheral proteins in the RBC membraneBlood, 2003
- Primaquine-Induced Hemolytic Anemia: Formation of Free Radicals in Rat Erythrocytes Exposed to 6-Methoxy-8-hydroxylaminoquinolineThe Journal of pharmacology and experimental therapeutics, 2002
- Primaquine-Induced Hemolytic Anemia: Effect of 6-Methoxy-8-hydroxylaminoquinoline on Rat Erythrocyte Sulfhydryl Status, Membrane Lipids, Cytoskeletal Proteins, and MorphologyThe Journal of pharmacology and experimental therapeutics, 2002
- Absence of CD47 in protein 4.2-deficient hereditary spherocytosis in man: an interaction between the Rh complex and the band 3 complexBlood, 2002
- Formation of Free Radicals and Protein Mixed Disulfides in Rat Red Cells Exposed to Dapsone HydroxylamineFree Radical Biology & Medicine, 1997
- Oxidative Damage Does Not Alter Membrane Phospholipid Asymmetry in Human ErythrocytesBiochemistry, 1997
- Identification of free radicals produced in rat erythrocytes exposed to hemolytic concentrations of phenylhydroxylamineFree Radical Biology & Medicine, 1995
- Generation of Prothrombin‐Converting Activity and the Exposure of Phosphatidylserine at the Outer Surface of PlateletsJBIC Journal of Biological Inorganic Chemistry, 1982